Results 171 to 180 of about 49,818 (236)

Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer. [PDF]

Cancer Discov
Siegel F, Siegel S, Kotýnková K, Karsli Uzunbas G, Korr D, Tomono H, Andersen S, Denney D, Berger M, Schulze VK, Lewis TA, Kaplan B, Golfier S, Mortier J, Hillig RC, Boemer U, Petersen K, Eis K, Williams S, Rüttinger D, Cherniack AD, Loong HH, Goto K, Grassi P, Meyerson M, Greulich H.   +25 more
europepmc   +1 more source

<i>GPR176</i> represses mitophagy to promote the progression of osteosarcoma by facilitating mTORC1 activity via PI3K-AKT pathway. [PDF]

Transl Cancer Res
Jiang J, Zheng B, Wang J, Fang Y, Yang L, Lv J, Liang H.   +6 more
europepmc   +1 more source

Targeting PLK1 potentiates the antitumor efficacy of EGFR-TKIs through inhibiting the JAK1/STAT3 pathway. [PDF]

Cell Death Dis
Li C, Shi S, Li L, Wang Y, Yao M, Yu C, Yu C, Xie C.   +7 more
europepmc   +1 more source

Human Mesenchymal Stromal Cells Derived from Different Tissues Show Similar Profiles of c-ErbB Receptor Family Expression at the mRNA and Protein Levels. [PDF]

Int J Mol Sci
Kosheverova V, Kharchenko M, Kamentseva R, Kotov M, Schwarz A, Kuneev I, Kotova A, Enukashvily N, Kornilova E.   +8 more
europepmc   +1 more source

Increased activation of ErbB and NF-κB signalling pathways in Darier disease affected skin. [PDF]

J Eur Acad Dermatol Venereol
Ernst N, Ludwig RJ, Vorobyev A.
europepmc   +1 more source

ERBB2 I655V mutation correlates with efficacy of immunotherapy in gallbladder cancer. [PDF]

World J Surg Oncol
Gao Q, You YN, Lian S, Pan C, Zhang ZL, Li KS.   +5 more
europepmc   +1 more source

ErbB signaling and cell cycle pathways associated with trastuzumab deruxtecan resistance in HER2-positive metastatic breast cancer: a case report. [PDF]

AME Case Rep
Gao HF, Lin YY, Lv XZ, Li H, Xu FP, Wang K.   +5 more
europepmc   +1 more source

Massive breast fat necrosis with invasive breast cancer: A case report. [PDF]

Oncol Lett
Zhang A, Song L, Yang X, Chen X, Tian B, Li Y, Jiang G, Jiang L.   +7 more
europepmc   +1 more source